OMHE

Omni Health, Inc. OMHE

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode OMHE NVOS ADVT BBBT PBLA ACGI LGND ARMM SONX EHOS
6M 200.00 % 25.00 % 0.00 % 0.00 % -99.87 % 0.00 % 75.70 % 0.00 % -87.83 % 0.00 %
YTD 200.00 % -95.04 % 0.00 % 0.00 % -99.93 % 0.00 % 84.86 % 0.00 % -92.35 % 900.00 %
1Y 200.00 % -92.75 % 0.00 % 0.00 % -99.91 % 0.00 % 76.12 % 0.00 % -92.43 % 900.00 %
3Y -40.00 % -99.87 % -90.00 % -88.89 % -100.00 % -90.00 % 199.00 % -99.82 % -99.95 % -90.00 %
5Y -85.00 % -99.94 % -97.50 % -99.79 % -100.00 % -98.33 % 94.24 % -99.98 % -99.99 % 49 900.00 %
10Y -99.57 % -99.94 % -99.83 % -97.56 % -100.00 % -97.50 % 86.73 % -99.98 % -99.99 % 9 999 900.00 %
From the beginning 50.00 % -99.94 % -100.00 % -99.99 % -100.00 % -100.00 % 337.11 % -99.98 % -99.99 % -66.67 %

Dividend

Ligand Pharmaceuticals Incorporated